Published in Lab Law Weekly, May 22nd, 2009
For the first quarter ended March 28, 2009, net sales were $412.1 million, as compared to $534.3 million for the same period in the previous year. For the quarter ended March 28, 2009, the Company recorded a net loss of $4.3 million, or $0.08 per share, compared to a net loss of $3.4 million, or $0.06 per share, in the quarter ended March 29, 2008. On a Non-GAAP basis, loss from continuing operations was $7.6 million, or $0.14 per diluted share for the first quarter of 2009. Non-GAAP income (loss) from continuing operations excludes integration, acquisition and other charges,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.